Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP Review Of Claims Lights Fire Under Smoking-Cessation Marketer

This article was originally published in The Tan Sheet

Executive Summary

Final Smoke Inc. voluntarily modifies claims for its smoking-cessation system, including a dietary supplement and homeopathic detoxification liquid, in conjunction with an Electronic Retailing Self-Regulation Program review

You may also be interested in...



ERSP on CigArrest

CigArrest, marketer of the eponymous smoking cessation program, has adequately supported its general performance and safety claims, but should modify or discontinue its claim that users can "become a non-smoker in as little as seven days," according to an Electronic Retailing Self-Regulation Program decision Feb. 24. ERSP reviewed a TV ad and website promoting the product and expressed concern about claims such as: "clinically proven methods to help you avoid smoking in any situation" and "the most successful stop smoking program." However, the National Advertising Review Council division found that ingredient claims such as "the active ingredients work...by relieving nervous tension, irritability and the craving associated with withdrawal" were given "adequate" support by scientific literature. Additionally, safety claims including "all-natural, non-addictive" and "we have not had any serious reactions or adverse side-effects ever reported" were reasonably supported by the marketer, ERSP states. CigArrest is a homeopathic formula that includes Nux Vomica (poison nut) and Plantago Major (plantain), the marketer states...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel